Home › Asset managers › Compare 2024-2025 › TIAA vs Lincoln Financial
TIAA 2024-2025 · Lincoln Financial 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 72,648 | 63,965 | 4,302 | 4,381 | 93.7% | 91.6% |
| Board proposals | 59,220 | 51,622 | 3,891 | 3,707 | 93.0% | 90.8% |
| E&S shareholder proposals | 257 | 127 | 25 | 105 | 83.6% | 73.1% |
| Other items | 13,171 | 12,216 | 386 | 569 | 96.9% | 95.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
8,683 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | TIAA | Lincoln Financial |
|---|---|---|---|---|---|---|
| CORMEDIX INC. | November 21, 2024 | To approve an amendment to the Amended and Restated 2019 Omnibus Stock Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CORMEDIX INC. | June 24, 2025 | Election of Directors: Janet Dillione Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 2 funds |
| CORMEDIX INC. | June 24, 2025 | Election of Directors: Robert Stewart Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 2 funds |
| CORPORATE TRAVEL MANAGEMENT LTD. | October 31, 2024 | Approve Grant of Rights to Jamie Pherous Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Amount and Use of Proceeds Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Arrangement Relating to the Accumulated Profit Prior to the Issuance Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Authorization by the General Meeting to the Board and Its Authorized Person(s) to Proceed with Relevant Matters in Respect of the Issuance of Shares to Specific Target Subscribers by the Company in their Sole Discretion Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Class and Par Value of Shares to be Issued Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Dilution of the Company's Current Return by the Proposed Issuance of A Shares to Specific Target Subscribers and Remedial Measures Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Discussion and Analysis Report on the Proposal of the Issuance of A Shares to Specific Investor Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Feasibility Analysis Report on the Use of Proceeds from the Proposed Issuance of A Shares to Specific Target Subscribers by the Company Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Lock-Up Period Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Method and Time of Issuance Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Number of Shares to be Issued Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Place of Listing Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Preliminary Proposal of the Proposed Issuance of A Shares to Specific Target Subscribers Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Pricing Benchmark Date, Issue Price and Pricing Principle Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Report on Use of Proceeds from Previous Fund-Raising Activities of the Company Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Satisfaction of the Company of the Requirements for the Proposed Issuance of A Shares to Specific Target Subscribers Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Specific Mandate Related to the Proposed Issuance of A Shares to Specific Target Subscribers Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Target Subscribers and Method of Subscription Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Undertakings to be Made by the Relevant Entities in Respect of the Measures on the Dilution of the Company's Current Return by the Proposed Issuance of A Shares to Specific Target Subscribers Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Validity Period of the Resolution Prior to the Issuance Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COUCHBASE INC. | May 29, 2025 | Election of Class I Directors: Lynn M. Christensen Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 2 funds |
| COWELL E HOLDINGS INC. | May 29, 2025 | Elect Meng Yan as Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CRANSWICK PLC | July 29, 2024 | Approve Remuneration Policy Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CREDIT ACCEPTANCE CORP. | June 4, 2025 | Election of Directors: Glenda J. Flanagan Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 2 funds |
| CREDIT ACCEPTANCE CORP. | June 4, 2025 | Election of Directors: Scott J. Vassalluzzo Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 2 funds |
| CREDIT ACCEPTANCE CORP. | June 4, 2025 | Election of Directors: Thomas N. Tryforos Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 2 funds |
| CREDIT ACCEPTANCE CORP. | June 4, 2025 | Election of Directors: Vinayak R. Hegde Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 2 funds |
| CRICUT INC. | May 28, 2025 | Election of Directors: Ashish Arora Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 1 fund |
| CRICUT INC. | May 28, 2025 | Election of Directors: Billie Williamson Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 1 fund |
| CRICUT INC. | May 28, 2025 | Election of Directors: Melissa Reiff Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 1 fund |
| CRICUT INC. | May 28, 2025 | To approve, by non-binding vote, named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| CRONOS GROUP INC | July 19, 2024 | ADOPTION OF AN ADVISORY (NON-BINDING) RESOLUTION TO APPROVE THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT DATED APRIL 26, 2024 Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CRONOS GROUP INC. | July 19, 2024 | Election of Directors: Dominik Meier Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CRONOS GROUP INC. | July 19, 2024 | Election of Directors: Kamran Khan Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CRONOS GROUP INC. | July 19, 2024 | Election of Directors: Michael Gorenstein Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| CRONOS GROUP INC. | June 20, 2025 | Election of Directors: Dominik Meier Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CRONOS GROUP INC. | June 20, 2025 | Election of Directors: Elizabeth Seegar Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CRONOS GROUP INC. | June 20, 2025 | Election of Directors: James Rudyk Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CRONOS GROUP INC. | June 20, 2025 | Election of Directors: Jason Adler Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CRONOS GROUP INC. | June 20, 2025 | Election of Directors: Kamran Khan Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CRONOS GROUP INC. | June 20, 2025 | Election of Directors: Michael Gorenstein Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| CRONOS GROUP INC. | June 20, 2025 | Election of Directors: Murray Garnick Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CROSS COUNTRY HEALTHCARE INC. | February 28, 2025 | To approve on an advisory (non-binding) basis the compensation that may be paid or become payable to Cross Country's named executive officers that is based on or otherwise relates to the merger. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| CROWDSTRIKE HOLDINGS INC. | June 18, 2025 | To elect CrowdStrike's nominees Cary J. Davis, George Kurtz and Laura J. Schumacher to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders: Cary J. Davis Director Elections |
Board | For | FOR 10 funds |
WITHHOLD 2 funds |
| CRYOPORT INC. | June 6, 2025 | To elect six directors: Linda Baddour Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 5 funds |
| CRYOPORT INC. | June 6, 2025 | To elect six directors: Ramkumar Mandalam, PhD Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 5 funds |
| CRYOPORT INC. | June 6, 2025 | To elect six directors: Robert Hariri, MD, PhD Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 5 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Attribution of Profit and Loss During the Transition Period Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Audit Report, Pro Forma Review Report and Valuation Report in Relation to the Transaction Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Authorization of the Board and Its Authorized Persons to Handle All Related Matters Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transaction and Validity of the Submitted Legal Documents Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Confidentiality Measures and Confidentiality System Adopted for This Transaction Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Description of the Basis and Fairness and Reasonableness of the Pricing of the Transaction Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Distribution Arrangement of Undistributed Earnings Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Fluctuation of the Company's Stock Price Before the Release of Information on This Transaction Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken and Commitment from Relevant Parties Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Method and Purpose and Approach as Well as the Fairness of Pricing Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount and Number of Issues Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Manner and Target Subscribers Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Type, Par Value and Listing Location Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Lock-Up Period Arrangement Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Overall Plan Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Performance Commitment and Compensation Arrangement Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Pricing Reference Date and Issue Price Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Purchases and Sales of Assets in the Twelve Months Prior to the Transaction Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report (Draft) and Summary on Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds and Related Party Transactions Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report on the Usage of Previously Raised Funds Capital Structure |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Resolution Validity Period Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Signing of Conditional Agreement to the Issuance of Shares and Acquisition by Cash as well as Performance Compensation Agreement Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Target Assets Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 18 and 21 of the Measures for the Continuous Supervision of ChiNext Listed Companies (Trial) and Article 8 of the Shenzhen Stock Exchange Listed Company Major Asset Restructuring Review Rules Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 4 of Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with the Relevant Provisions of the Administrative Measures for the Registration of Securities Issuance of Listed Companies Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Constitute as Major Asset Restructuring and Does Not Constitute as Restructuring and Listing Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Parties Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Price and Payment Method Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Use of Proceeds Capital Structure |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Company's Plan for Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds Complies with Relevant Laws and Regulations Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Relevant Entity of Transaction Does Not Exist in Article 12 of Listed Company Supervision Guidelines No. 7 and Article 30 of the Guidelines for Self-regulatory Supervision No. 8 (Revised in 2023) Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CTBC FINANCIAL HOLDING CO. LTD. | June 13, 2025 | Approve Issuance of Restricted Stocks Compensation |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CTO REALTY GROWTH INC. | June 18, 2025 | Election of Directors: Mr. Christopher J. Drew Director Elections |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| CTO REALTY GROWTH INC. | June 18, 2025 | Election of Directors: Mr. Christopher W. Haga Director Elections |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| CTO REALTY GROWTH INC. | June 18, 2025 | Election of Directors: Mr. R. Blakeslee Gable Director Elections |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| CTS EVENTIM AG & CO. KGAA | May 21, 2025 | Approve Remuneration Policy Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| CTS EVENTIM AG & CO. KGAA | May 21, 2025 | Approve Remuneration Report Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| CUBESMART | May 20, 2025 | Election of Trustees: Piero Bussani Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 5 funds |
| CULLEN/FROST BANKERS INC. | April 30, 2025 | To provide nonbinding approval of executive compensation; Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 4 funds |
| CURTISS-WRIGHT CORP. | May 8, 2025 | Election of Directors: Dean M. Flatt Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 8 funds |
| CUSTOMERS BANCORP INC. | May 27, 2025 | Election of Directors: Andrea R. Allon Director Elections |
Board | For | AGAINST 9 funds |
FOR 5 funds |
| CUSTOMERS BANCORP INC. | May 27, 2025 | Election of Directors: Daniel K. Rothermel Director Elections |
Board | For | AGAINST 9 funds |
FOR 5 funds |
| CVC CAPITAL PARTNERS PLC | May 20, 2025 | Approve Remuneration Report Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CVC CAPITAL PARTNERS PLC | May 20, 2025 | Authorise Audit Committee to Fix Remuneration of Auditors Audit-related |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CVC CAPITAL PARTNERS PLC | May 20, 2025 | Elect Rolly van Rappard as Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CVC CAPITAL PARTNERS PLC | May 20, 2025 | Ratify Deloitte LLP as Auditors Audit-related |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CVS GROUP PLC | November 20, 2024 | Approve Remuneration Report Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
← Previous Page 14 of 87 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.